Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 37. Отображено 37.
19-09-2019 дата публикации

2, 4, 5-SUBSTITUTED PYRIMIDINE DERIVATIVES, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT

Номер: WO2019177375A1
Принадлежит:

The present invention relates to 2, 4, 5-substituted pyrimidine derivatives, a method for preparing same, and a pharmaceutical composition for preventing or treating cancer comprising same as an active ingredient. Since the compound exhibits a high inhibitory ability against the epidermal growth factor receptor (EGFR) wild type or mutation, the compound can be effectively used for the treatment of cancer expressing the EGFR wild type or EGFR mutation. The compound has an excellent ability to inhibit the proliferation of lung cancer cell lines and can be particularly useful for the treatment of lung cancer.

Подробнее
02-04-2018 дата публикации

NOVEL IMIDAZOLYL PYRIMIDINE DERIVATIVES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTING OR TREATING CANCER CONTAINING SAME AS ACTIVE INGREDIENT

Номер: KR1020180032784A
Принадлежит:

The present invention relates to a novel imidazolium pyrimidine derivative, a preparation method thereof, and a pharmaceutical composition for preventing or treating cancer containing the same as an active ingredient. The imidazolium pyrimidine derivatives, optical isomers thereof or pharmaceutically acceptable salts thereof according to the present invention are useful not only for an activity of a Wee1 kinase, but also has an excellent effect in inhibiting cell proliferation of liver cancer cell line such that the present invention can be usefully used as a pharmaceutical composition for preventing or treating Wee1 kinase related diseases such as liver cancer preferably, and solid cancer such as liver cancer, lung cancer, colorectal cancer, stomach cancer, breast cancer, colon cancer, bone cancer, pancreatic cancer, head or neck cancer, uterine cancer, ovarian cancer, rectal cancer, esophageal cancer, small bowel cancer, cancer nearby an anus, fallopian tube cancer, endometrial carcinoma ...

Подробнее
19-09-2019 дата публикации

2, 4, 5-SUBSTITUTED PYRIMIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER OR INFLAMMATORY DISEASE

Номер: WO2019177374A1
Принадлежит:

The present invention relates to a 2, 4, 5-substituted pyrimidine derivative, a preparation method therefor, and a pharmaceutical composition comprising same as an effective ingredient for prevention or treatment of cancer or inflammatory disease. The compound exhibits high inhibitory activity against wild-type or mutant epidermal growth factor receptor (EGFR) and has an excellent inhibitory effect on JAK3, thus finding useful applications in the treatment of wild-type or mutant EGFR-expressed cancer or cancer or inflammatory disease associated with the activity of JAK3. Particularly, the compound can be useful for the treatment of lung cancer thanks to the excellent inhibitory activity thereof against the growth of lung cancer cell lines.

Подробнее
08-10-2015 дата публикации

PYRAZINE FUSED-RING DERIVATIVES HAVING TAK1 INHIBITION ACTIVITY

Номер: KR1020150113801A
Принадлежит:

A compound selected from pyrazine fused-ring derivatives of a chemical formula 1 or pharmaceutically acceptable salts thereof has excellent inhibition activity with respect to TAK1 kinase. A pharmaceutical composition comprising the same is capable of increasing activity of anticancer drugs with respect to cancer or tumor by inhibiting activation of TAK1 kinase, with excellent effects as a prevention agent or a therapeutic agent of cancer or tumor. In the chemical formula 1, A, X, Y, W, Z, E, R^1, and m are the same as defined in the specification. COPYRIGHT KIPO 2016 ...

Подробнее
27-09-2018 дата публикации

PYRROLO-PYRIDINE DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF PROTEIN KINASE-RELATED DISEASES

Номер: WO2018174650A1
Принадлежит:

The present invention relates to a pyrrolo-pyridine derivative compound, a method for preparing the same, and a pharmaceutical composition containing the same as an active ingredient for prevention or treatment of protein kinase-related diseases. A compound represented by chemical formula 1, an optical isomer thereof, or a pharmaceutically acceptable salt thereof, according to the present invention, has excellent inhibitory activity against various protein kinases including DYRK1A, and therefore, the pharmaceutical composition containing the same as an active ingredient can be favorably used in the treatment or prevention of protein kinase-related diseases. Particularly, the pharmaceutical composition can be effectively used in the prevention, treatment, or alleviation of Alzheimer's disease, dementia, or Alzheimer's dementia.

Подробнее
30-08-2018 дата публикации

PHARMACEUTICAL COMPOSITION COMPRISING COMPOUND CAPABLE OF PENETRATING BLOOD-BRAIN BARRIER AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING BRAIN CANCER

Номер: WO2018155947A1
Принадлежит:

The present invention relates to a pharmaceutical composition comprising a compound capable of penetrating the blood-brain barrier as an effective ingredient for preventing or treating brain cancer. A pharmaceutical composition for preventing or treating brain cancer according to the present invention efficiently penetrates the blood-brain barrier of the brain to effectively inhibit LRRK2 protein, thus finding useful applications in the prevention or treatment of brain cancer.

Подробнее
07-01-2016 дата публикации

PYRIMIDINE DERIVATIVE COMPOUND AND USES THEREOF

Номер: KR1020160002318A
Принадлежит:

The present invention relates to a novel pyrimidine derivative compound having inhibitory activities with respect to TAK1 kinase, and to a pharmaceutical composition comprising the same for preventing or treating cancer or tumor. According to the present invention, pyrimidine derivatives in chemical formula 1 can be usefully used as a medicine or a prevention agent of cancer or tumor, with excellent inhibitory activities with respect to TAK1 kinase. The compound is selected from the pyrimidine derivatives in the chemical formula 1, pharmaceutically acceptable salt thereof, an optical isomer thereof, a hydrate thereof, and a solvate thereof. COPYRIGHT KIPO 2016 ...

Подробнее
28-12-2017 дата публикации

NOVEL IMIDAZOPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER

Номер: WO2017222287A1
Принадлежит:

The present invention relates to a novel imidazopyridine derivative, a method for preparing same, and a pharmaceutical composition containing same as an active ingredient for preventing or treating cancer. The novel imidazopyridine derivative according to the present invention, a stereoisomer thereof, and pharmaceutically acceptable salts thereof can effectively inhibit cancer cell-related kinase, are excellent in inhibiting the proliferation of cancer cells in a cancer cell line, and effectively inhibit the proliferation of cancer cells (cancer cell apoptosis) in a cancer cell heterograft model, and thus can be useful in a pharmaceutical composition containing same as an active ingredient for preventing or treating cancer. Also, the novel imidazopyridine derivative according to the present invention, the stereoisomer thereof, and the pharmaceutically acceptable salts thereof can effectively inhibit Src and Fyn, thereby being useful in a pharmaceutical composition for preventing or treating ...

Подробнее
06-12-2018 дата публикации

PYRROLO-PYRIMIDINE DERIVATIVE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME COMPOUND AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASE

Номер: WO2018155916A3
Принадлежит:

The present invention relates to a novel pyrrolo-pyrimidine derivative compound, a preparation method therefor, and a pharmaceutical composition comprising the same compound as an effective ingredient for preventing or treating a protein kinase-related disease. The compound represented by Chemical Formula 1 according to the present invention, an optical isomer thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an effective ingredient has outstanding inhibitory activity against LRRK2 kinase and against phosphorylation in the NIH-3T3 cell line, which is an LRRK2-expressing cell line, and NCC01 and 448T cell lines, which are both derived from patients with brain tumors. Verified to have inhibitory activity against various protein kinases in addition to LRRK2, the compound can find effective applications in the treatment or prevention of protein kinase-related diseases.

Подробнее
28-09-2017 дата публикации

NOVEL PYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FGFR-RELATED DISEASE CONTAINING SAME AS ACTIVE COMPONENT

Номер: WO2017164705A1
Принадлежит:

The present invention relates to a novel pyridine derivative, a method for preparing same, and a pharmaceutical composition which contains same as an active component and is for preventing or treating fibroblast growth factor receptor (FGFR)-related disease. A novel pyridine derivative according to the present invention, an optical isomer thereof, and a pharmaceutically acceptable salt of the pyridine derivative can effectively inhibit a fibroblast growth factor receptor (FGFR), and thus FGFR-related disease, preferably has a useful effect on the prevention and treatment of cancer.

Подробнее
11-06-2020 дата публикации

2, 4, 5-SUBSTITUTED PYRIMIDINE DERIVATIVES, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT

Номер: WO2019177375A8
Принадлежит:

The present invention relates to 2, 4, 5-substituted pyrimidine derivatives, a method for preparing same, and a pharmaceutical composition for preventing or treating cancer comprising same as an active ingredient. Since the compound exhibits a high inhibitory ability against the epidermal growth factor receptor (EGFR) wild type or mutation, the compound can be effectively used for the treatment of cancer expressing the EGFR wild type or EGFR mutation. The compound has an excellent ability to inhibit the proliferation of lung cancer cell lines and can be particularly useful for the treatment of lung cancer.

Подробнее
10-09-2018 дата публикации

PYRROLO-PYRIDINE DERIVATIVE COMPOUND, METHOD FOR MANUFACTURING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASE CONTAINING SAME AS ACTIVE INGREDIENT

Номер: KR101896568B1

The present invention relates to a pyrrolo-pyridine derivative compound, a method for manufacturing the same, and a pharmaceutical composition for preventing or treating a protein kinase-related disease containing the compound as an active ingredient. The compound represented by chemical formula 1, an optical isomer thereof or a pharmaceutically acceptable salt thereof according to the present invention is excellent in an inhibitory activity against various protein kinases including DYRK1A. Therefore, a pharmaceutical composition containing the compound as an active ingredient can be usefully used for treating or preventing a protein kinase-related disease. In particular, the compound can be effectively used for prevention, treatment or alleviation of Alzheimer′s disease, dementia or Alzheimer′s dementia. COPYRIGHT KIPO 2018 ...

Подробнее
24-12-2018 дата публикации

NOVEL 2,3,5-SUBSTITUTED THIOPHENE COMPOUND AS PROTEIN KINASE INHIBITOR

Номер: KR1020180136425A
Принадлежит:

The present invention relates to a novel 2,3,5-substituted thiophene compound having inhibitory activity against kinases, an anticancer agent comprising the compound as an active ingredient, and a method of preparing the compound. COPYRIGHT KIPO 2019 ...

Подробнее
24-08-2017 дата публикации

NOVEL 2,3,5-SUBSTITUTED THIOPHENE COMPOUND AS PROTEIN KINASE INHIBITOR

Номер: KR1020170096599A
Принадлежит:

The present invention relates to a novel 2,3,5-substituted thiophene compound having inhibitory activity against kinases, an anticancer agent comprising the compound as an active ingredient, and a method of preparing the compound. According to the present invention, the 2,3,5-substituted thiophene compound has inhibitory activity on the proliferation of FLT3-ITD-positive leukemia cell line and Ba/F3 cell line, and has superior inhibitory activity on drug-resistant FLT3 mutations as well, and thus is effective in the treatment of acute myeloid leukemia. COPYRIGHT KIPO 2017 ...

Подробнее
12-12-2018 дата публикации

PYRROLOPYRIMIDINE DERIVATIVE COMPOUND, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASES PYRROLOPYRIMIDINE DERIVATIVE COMPOUND

Номер: KR1020180132575A
Принадлежит:

The present invention relates to a noble pyrrolopyrimidine derivative compound, a preparation method thereof, and a pharmaceutical composition for preventing or treating protein kinase-related diseases comprising the pyrrolopyrimidine derivative compound as an active ingredient. According to the present invention, a compound represented by chemical formula 1, optical isomers thereof or pharmaceutically acceptable salts thereof, and a pharmaceutical composition comprising the compound as an active ingredient have superior inhibiting activities with respect to LRRK2 kinase and have excellent phosphorylation inhibiting effects in NIH-3T3 cell line, LRRK2 expression cell line, and NCC01 and 448T cell lines, cell lines derived from a brain tumor patient. Further, it has been checked through experiments that the compound, the optical isomers or the pharmaceutically acceptable salts, and the pharmaceutical composition have inhibiting activities with respect to various protein kinases in addition ...

Подробнее
23-07-2020 дата публикации

PYRROLOPYRIMIDINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASE COMPRISING SAME AS ACTIVE INGREDIENT

Номер: WO2020149723A1
Принадлежит:

The present invention relates to a pyrrolopyrimidine derivative, and a pharmaceutical composition for preventing or treating protein kinase-related disease comprising same as an active ingredient. The pyrrolopyrimidine derivative has excellent inhibitory activity against various protein kinases including LRRK2, and has an excellent effect of inhibiting proliferation of triple negative breast cancer cells. Therefore, the pharmaceutical composition comprising the pyrrolopyrimidine derivative as an active ingredient may be useful for the treatment or prevention of protein kinase-related diseases, in particular cancer, degenerative brain disease, and inflammatory disease, and specifically, may be useful for the treatment of triple negative breast cancer.

Подробнее
14-11-2019 дата публикации

NOVEL COMPOUND EXHIBITING ENTEROPEPTIDASE INHIBITORY ACTIVITY

Номер: WO2019216742A1
Принадлежит:

The present invention relates to: a novel compound exhibiting enteropeptidase inhibitory activity; a pharmaceutically acceptable salt thereof; a pharmaceutical composition for metabolic diseases such as obesity, diabetes, or hyperlipidemia, including the compound or a pharmaceutically acceptable salt thereof; and a method for preventing or treating metabolic diseases using the novel compound. The compound of the present invention enables, due to excellent enteropeptidase inhibitory activity, not only fats but also proteins to be excreted when ingested foods are excreted, not absorbed, from the body, resulting in fewer side effects such as fatty stool, and acts only on the gastrointestinal tract, thus reducing side effects such as depression. Thus, the compound of the present invention is very useful as an agent for the treatment or prevention of various metabolic diseases such as obesity, diabetes, and hyperlipidemia.

Подробнее
27-09-2018 дата публикации

PYRROLO-PYRIDINE DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF PROTEIN KINASE-RELATED DISEASES

Номер: WO2018174650A9
Принадлежит:

The present invention relates to a pyrrolo-pyridine derivative compound, a method for preparing the same, and a pharmaceutical composition containing the same as an active ingredient for prevention or treatment of protein kinase-related diseases. A compound represented by chemical formula 1, an optical isomer thereof, or a pharmaceutically acceptable salt thereof, according to the present invention, has excellent inhibitory activity against various protein kinases including DYRK1A, and therefore, the pharmaceutical composition containing the same as an active ingredient can be favorably used in the treatment or prevention of protein kinase-related diseases. Particularly, the pharmaceutical composition can be effectively used in the prevention, treatment, or alleviation of Alzheimer's disease, dementia, or Alzheimer's dementia.

Подробнее
27-02-2020 дата публикации

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BRAIN CANCER, COMPRISING, AS ACTIVE INGREDIENT, COMPOUND CAPABLE OF PENETRATING BLOOD-BRAIN BARRIER

Номер: WO2020040610A1
Принадлежит:

The present invention relates to a pharmaceutical composition for preventing or treating brain cancer, comprising, as an active ingredient, a compound capable of penetrating the blood-brain barrier. The pharmaceutical composition for preventing or treating brain cancer, according to the present invention, efficiently penetrates the blood-brain barrier of the brain and effectively inhibits an LRRK2 protein, thereby being effectively usable in the prevention or treatment of brain cancer.

Подробнее
30-08-2018 дата публикации

PYRROLOPYRIMIDINE DERIVATIVE COMPOUND, METHOD FOR MANUFACTURING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASE CONTAINING COMPOUND AS ACTIVE INGREDIENT

Номер: KR1020180097162A
Принадлежит:

The present invention relates to a novel pyrrolopyrimidine derivative compound, a method for manufacturing the same, and a pharmaceutical composition for preventing or treating a protein kinase-related disease containing the compound as an active ingredient. The pharmaceutical composition comprising the compound represented by chemical formula 1, an optical isomer thereof or a pharmaceutically acceptable salt thereof as an active ingredient is excellent in inhibitory activity against LRRK2 kinase and is excellent in phosphorylation inhibition of an LRRK2 expressing NIH-3T3 cell line, and NCC01 and 448T cell lines derived from brain tumor patients. Furthermore, since the composition is confirmed through experimentation to have inhibitory activity against various protein kinases including LRRK2, the composition can be effectively used for the treatment or prevention of protein kinase-related diseases. COPYRIGHT KIPO 2018 ...

Подробнее
29-12-2017 дата публикации

NOVEL IMIDAZOPYRIDINE DERIVATIVES, METHOD OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT

Номер: KR1020170143456A
Принадлежит:

The present invention relates to a novel imidazopyridine derivative, a method of preparing the same, and a pharmaceutical composition comprising the same as an active ingredient for preventing or treating cancer. The novel imidazopyridine derivative according to the present invention, a stereoisomer thereof, and pharmaceutically acceptable salts thereof can effectively inhibit cancer-related kinase, are excellent in inhibiting proliferation of cancer cells in a cancer cell line, and effectively inhibit proliferation of cancer cells (cancer cell apoptosis) in a cancer cell heterograft model, and thus can be useful as a pharmaceutical composition comprising the same as an active ingredient for preventing or treating cancer. Also, the novel imidazopyridine derivative according to the present invention, the stereoisomer thereof, and the pharmaceutically acceptable salts thereof can effectively inhibit Src and Fyn, thereby being useful as a pharmaceutical composition for preventing or treating ...

Подробнее
18-06-2020 дата публикации

2, 4, 5-SUBSTITUTED PYRIMIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER OR INFLAMMATORY DISEASE

Номер: WO2019177374A8
Принадлежит:

The present invention relates to a 2, 4, 5-substituted pyrimidine derivative, a preparation method therefor, and a pharmaceutical composition comprising same as an effective ingredient for prevention or treatment of cancer or inflammatory disease. The compound exhibits high inhibitory activity against wild-type or mutant epidermal growth factor receptor (EGFR) and has an excellent inhibitory effect on JAK3, thus finding useful applications in the treatment of wild-type or mutant EGFR-expressed cancer or cancer or inflammatory disease associated with the activity of JAK3. Particularly, the compound can be useful for the treatment of lung cancer thanks to the excellent inhibitory activity thereof against the growth of lung cancer cell lines.

Подробнее
21-12-2018 дата публикации

신규한 이미다조피리딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물

Номер: KR0101931435B1

... 본 발명은 신규한 이미다조피리딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물에 관한 것으로, 본 발명에 따른 신규한 이미다조피리딘 유도체, 이의 입체 이성질체 및 이의 약학적으로 허용 가능한 염은, 암세포 관련 효소(kinase)를 효과적으로 저해할 수 있고, 암 세포주에서 암의 세포 증식을 우수하게 억제할 수 있을 뿐 아니라, 암 세포 이종이식 모델에서 또한 암세포 증식 억제(암 세포 사멸) 효과가 있는 바, 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물로 유용하게 사용될 수 있다. 또한, 본 발명에 따른 신규한 이미다조피리딘 유도체, 이의 입체 이성질체 및 이의 약학적으로 허용 가능한 염은, Src 및 Fyn을 효과적으로 저해할 수 있는 바, 이와 관련된 질환의 예방 또는 치료용 약학적 조성물로 유용할 수 있고, 특히 동물 모델 실험에서 당뇨병성 신증에 유용할 수 있음을 확인한 바, 본 발명 화합물은 이를 유효성분으로 함유하는 당뇨병성 신증의 예방 또는 치료용 약학적 조성물로 유용한 효과가 있다.

Подробнее
03-09-2020 дата публикации

N-CONTAINING HETEROARYL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT

Номер: WO2020175968A1
Принадлежит:

The present invention relates to an N-containing heteroaryl derivative and a pharmaceutical composition for the prevention or treatment of cancer, comprising same as an active ingredient, wherein the derivative exhibits high inhibitory activity against various protein kinases, particularly high inhibitory efficacy against ret proto-oncogene (RET) enzymes, and has an excellent effect of inhibiting the proliferation of medullary thyroid cancer cells and lung cancer cells, which express the RET fusion gene, and thus can be effectively used in the treatment of cancer, for example, medullary thyroid cancer or lung cancer. In particular, the derivative can be effectively used in the treatment of cancer in which the RET fusion gene is expressed.

Подробнее
29-03-2018 дата публикации

NOVEL IMIDAZOLYL PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER

Номер: WO2018056621A1
Принадлежит:

The present invention relates to a novel imidazolyl pyrimidine derivative, a method for preparing the same, and a pharmaceutical composition comprising the same as an active ingredient for prevention or treatment of cancer.

Подробнее
08-07-2016 дата публикации

THIAZOLIDINE DERIVATIVE COMPOUND AND USES THEREOF

Номер: KR1020160081485A
Принадлежит:

The present invention relates to a novel thiazolidine derivative compound having inhibitory activities with respect to TAK1 kinase, and to a pharmaceutical composition for preventing or treating cancer or tumor, comprising the same. According to the present invention, the thiazolidine derivative of chemical formula 1 has excellent inhibitory activities with respect to TAK1 kinase, thereby being efficiently used as an agent for treating or preventing cancer or tumor. COPYRIGHT KIPO 2016 ...

Подробнее
13-10-2017 дата публикации

NOVEL PYRIDINE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING FGFR-ASSOCIATED DISEASES CONTAINING SAME AS ACTIVE INGREDIENT

Номер: KR1020170114254A
Принадлежит:

The present invention relates to a novel pyridine derivative, a production method thereof, and a pharmaceutical composition for preventing and treating fibroblast growth factor receptor (FGFR)-associated diseases containing the same as an active ingredient according to the present invention, the novel pyridine derivative, an optical isomer thereof, and a pharmaceutically acceptable salt thereof effectively inhibits FGFR, thereby being useful for preventing or treating FGFR-associated diseases, favorably cancer. COPYRIGHT KIPO 2017 ...

Подробнее
28-12-2017 дата публикации

NOVEL IMIDAZOPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER

Номер: WO2017222285A1
Принадлежит:

The present invention relates to a novel imidazopyridine derivative, a method for preparing same, and a pharmaceutical composition containing same as an active ingredient for preventing or treating cancer. The novel imidazopyridine derivative according to the present invention, a stereoisomer thereof, and pharmaceutically acceptable salts thereof can effectively inhibit cancer-related kinase, are excellent in inhibiting proliferation of cancer cells in a cancer cell line, and effectively inhibit proliferation of cancer cells (cancer cell apoptosis) in a cancer cell heterograft model, and thus can be useful as a pharmaceutical composition containing same as an active ingredient for preventing or treating cancer. Also, the novel imidazopyridine derivative according to the present invention, the stereoisomer thereof, and the pharmaceutically acceptable salts thereof can effectively inhibit Src and Fyn, thereby being useful as a pharmaceutical composition for preventing or treating related ...

Подробнее
24-08-2017 дата публикации

NOVEL 2,3,5-SUBSTITUTED THIOPHENE COMPOUND AS PROTEIN KINASE INHIBITOR

Номер: WO2017142325A1
Принадлежит:

... [Summary] The present invention relates to a novel 2,3,5-substituted thiophene compound having an inhibitory activity against kinases, an anticancer agent comprising the compound as an active ingredient, and a preparation method of the compound.

Подробнее
23-07-2020 дата публикации

ARYL OR HETEROARYL DERIVATIVE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR TREATMENT OF KINASE-RELATED DISEASE

Номер: WO2020149553A1
Принадлежит:

The present invention relates to an aryl or heteroaryl derivative and a pharmaceutical composition comprising same as an active ingredient for treatment of kinase-related disease. An aryl or heteroaryl derivative provided according to an aspect of the present invention exhibits an excellent inhibitory activity against receptor-interacting serine/threonine-protein kinase 1 (RIPK1) and as such, can be used as a therapeutic agent for RIPK1-related disease.

Подробнее
30-08-2018 дата публикации

PYRROLO-PYRIMIDINE DERIVATIVE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME COMPOUND AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASE

Номер: WO2018155916A2
Принадлежит:

The present invention relates to a novel pyrrolo-pyrimidine derivative compound, a preparation method therefor, and a pharmaceutical composition comprising the same compound as an effective ingredient for preventing or treating a protein kinase-related disease. The compound represented by Chemical Formula 1 according to the present invention, an optical isomer thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an effective ingredient has outstanding inhibitory activity against LRRK2 kinase and against phosphorylation in the NIH-3T3 cell line, which is an LRRK2-expressing cell line, and NCC01 and 448T cell lines, which are both derived from patients with brain tumors. Verified to have inhibitory activity against various protein kinases in addition to LRRK2, the compound can find effective applications in the treatment or prevention of protein kinase-related diseases.

Подробнее
23-07-2020 дата публикации

PYRROLOPYRIDINE DERIVATIVE AND USE THEREOF IN PREVENTION AND TREATMENT OF PROTEIN KINASE-RELATED DISEASE

Номер: WO2020149715A1
Принадлежит:

The present invention relates to a pyrrolopyridine derivative and a pharmaceutical composition comprising same as an active ingredient for prevention or treatment of a protein kinase-related disease. The pyrrolopyridine derivative has excellent inhibitory activity against various protein kinases including LRRK2, DYRK1, and CLK1 and exhibits an excellent suppressive effect on the growth of triple-negative breast cancer cells. A pharmaceutical composition comprising same as an active ingredient can be advantageously used for treating or preventing protein kinase-related diseases, inter alia, cancer, degenerative brain diseases, and inflammatory diseases, and specifically for treating triple-negative breast cancer.

Подробнее
16-02-2016 дата публикации

CERAMIC NURSING BOTTLE CAPABLE OF CHECKING CONTENT CAPACITY AND MANUFACTURING METHOD THEREOF

Номер: KR1020160017426A
Принадлежит:

The present invention relates to a ceramic nursing bottle capable of checking content capacity, wherein the ceramic nursing bottle consists of porcelain plasticization-processed by a ceramic material and comprises: a nursing bottle main body having a screw unit fastened with a nipple member on an outer surface of an upper portion; and a transparent or translucent sight glass which is cured and is formed by plasticizing treatment after filling glaze inside a see through hole formed in a side of the nursing bottle main body. Therefore, contents and capacity in translucent ceramic nursing bottle can be easily checked by integrally providing plasticization-treated sight glass after filling high viscosity glaze. COPYRIGHT KIPO 2016 ...

Подробнее
16-01-2020 дата публикации

N-(3-(IMIDAZO[1,2-B]PYRIDAZINE-3-YLETHYNYL)-4-METHYLPHENYL)-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR TREATING KINASE-RELATED DISEASES

Номер: WO2020013531A1
Принадлежит:

This N-(3-(imidazo[1,2-b]pyridazine-3-ylethynyl)-4-methylphenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamide derivative has the effect of exhibiting excellent inhibitory activity against at least one kinase selected from the group consisting of ABL1, ABL2, AURKB, BRK, CDK11, CDK8, CDK9, CDKL2, CIT, DDR1, FLT3, FLT3, HIPK4, HUNK, JAK3, KIT, LOK, LTK, MET, MET, MLK2, MUSK, MYO3A, PAK3, PCTK3, PDGFRA, PDGFRB, RIPK1, TIE1 and ZAK, and thus being useable as a therapeutic agent for kinase-related diseases.

Подробнее
21-11-2018 дата публикации

신규한 이미다조피리딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물

Номер: KR0101920456B1

... 본 발명은 신규한 이미다조피리딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물에 관한 것으로, 본 발명에 따른 신규한 이미다조피리딘 유도체, 이의 입체 이성질체 및 이의 약학적으로 허용 가능한 염은, 암세포 관련 효소(kinase)를 효과적으로 저해할 수 있고, 암 세포주에서 암의 세포 증식을 우수하게 억제할 수 있을 뿐 아니라, 암 세포 이종이식 모델에서 또한 암세포 증식 억제(암 세포 사멸) 효과가 있는 바, 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물로 유용하게 사용될 수 있다. 또한, 본 발명에 따른 신규한 이미다조피리딘 유도체, 이의 입체 이성질체 및 이의 약학적으로 허용 가능한 염은, Src 및 Fyn을 효과적으로 저해할 수 있는 바, 이와 관련된 질환의 예방 또는 치료용 약학적 조성물로 유용할 수 있고, 예를 들어 당뇨병성 신증의 예방 또는 치료용 약학적 조성물로 유용한 효과가 있다.

Подробнее
29-12-2017 дата публикации

NOVEL IMIDAZOPYRIDINE DERIVATIVES, METHOD OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT

Номер: KR1020170143457A
Принадлежит:

The present invention relates to a novel imidazopyridine derivative, a method of preparing the same, and a pharmaceutical composition comprising the same as an active ingredient for preventing or treating cancer. The novel imidazopyridine derivative according to the present invention, a stereoisomer thereof, and pharmaceutically acceptable salts thereof can effectively inhibit cancer cell-related kinase, are excellent in inhibiting the proliferation of cancer cells in a cancer cell line, and effectively inhibit the proliferation of cancer cells (cancer cell apoptosis) in a cancer cell heterograft model, and thus can be useful in a pharmaceutical composition comprising the same as an active ingredient for preventing or treating cancer. Also, the novel imidazopyridine derivative according to the present invention, the stereoisomer thereof, and the pharmaceutically acceptable salts thereof can effectively inhibit Src and Fyn, thereby being useful in a pharmaceutical composition for preventing ...

Подробнее
27-02-2020 дата публикации

NOVEL USE OF PYRIMIDINE DERIVATIVE COMPRISING LRRK KINASE INHIBITOR AS EFFECTIVE INGREDIENT

Номер: WO2020040591A1
Принадлежит:

The present invention relates to a novel use of a pyrimidine derivative comprising an LRRK kinase inhibitor as an effective ingredient. A pharmaceutical composition, provided according to one aspect of the present invention, for prevention or treatment of at least one selected from pancreatic cancer, breast cancer, and lung cancer exhibits an excellent therapeutic effect on cancer in vitro and in vivo and, as such, can be advantageously used as a therapeutic agent for pancreatic cancer, breast cancer, and lung cancer.

Подробнее